Related Experiment Video

Updated: Oct 7, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor

T K Kwon1, J W Park

  • 1Department of Immunology, School of Medicine, Keimyung University, 194 Dong-San Dong, Jung-Gu, Taegu, 705-717, South Korea. kwontk@dsmc.or.kr

Biochemical and Biophysical Research Communications
|May 26, 2001
PubMed

Insights

Overexpressed p27(Kip1) inhibits CDK2 but not CDK6 in HeLa cells due to low binding affinity. This suggests cell-specific regulation of cyclin-dependent kinase activity by p27(Kip1).

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • p27(Kip1) is a cyclin-dependent kinase (CDK) inhibitor that regulates cell cycle progression.
  • Overexpression of p27(Kip1) is known to induce G1 cell cycle arrest.
  • CDK complexes, particularly CDK2 and CDK6, are crucial for cell cycle progression.

Purpose of the Study:

  • To investigate the differential effects of p27(Kip1) overexpression on CDK2 and CDK6 kinase activity in HeLa cells.
  • To determine the binding affinity of p27(Kip1) to CDK2 and CDK6 complexes.
  • To explore the role of pRb in the association of p27(Kip1) with CDK6/cyclin D complexes.

Main Methods:

  • Cell culture (HeLa cells and other human cell lines).
  • Western blotting to assess protein levels and complex formation.
  • Kinase assays to measure CDK2 and CDK6 activity.
  • Immunoprecipitation to study protein-protein interactions.

Main Results:

  • p27(Kip1) overexpression inhibited CDK2 kinase activity but not CDK6 kinase activity in HeLa cells.
  • Higher amounts of p27(Kip1) were associated with CDK2 compared to CDK6 in HeLa cells.
  • While CDK6 complexes typically contain p27(Kip1) in most cell lines, HeLa cells showed preferential association of p27(Kip1) with CDK2.
  • Low binding affinity between p27(Kip1) and CDK6 in HeLa cells was attributed to low levels of CDK6/cyclin D complexes.
  • Functional inactivation of pRb affected p27(Kip1) association with CDK6/cyclin D complexes.

Conclusions:

  • In HeLa cells, overexpressed p27(Kip1) preferentially inhibits CDK2 over CDK6 due to reduced binding affinity to CDK6.
  • The low binding affinity of p27(Kip1) to CDK6 in HeLa cells is linked to the availability of CDK6/cyclin D complexes.
  • pRb status influences the interaction between p27(Kip1) and CDK6/cyclin D, highlighting a complex regulatory mechanism.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...